Outlook Business on MSN
After Dr Reddy’s, Sun Pharma gets court nod to export weight-loss drug
The Delhi High Court has allowed Sun Pharma to manufacture and export semaglutide-based weight-loss drugs.Sun Pharma assured ...
The dispute centres on Novo Nordisk's Indian patents for semaglutide, which it markets globally as Ozempic and Wegovy for ...
Novo Nordisk Sun Pharma The approval marks a major win for Sun Pharma in its patent dispute with Danish drugmaker Novo Nordisk, the company that manufactures weight loss drug Ozempic ...
Danish pharma giant says in process of challenging earlier verdict, where court allowed Dr Reddy’s to make and export ...
Novo Nordisk and Sun Pharma face off in the Delhi High Court over semaglutide, with Sun Pharma halting domestic sales until the patent expires in March 2026.
The fresh plea follows a recent court order allowing Dr. Reddy’s Laboratories (DRL) to continue manufacturing and exporting ...
Sun Pharmaceutical Industries has announced the launch of its global innovative drug, Ilumya (tildrakizumab) in India for ...
Mumbai: Sun Pharma Laboratories Limited, a wholly owned subsidiary of Sun Pharma, is set to establish a Rs 3,000-crore ...
Pharma's post-Covid growth faces challenges as margin compression and strategic shifts emerge in 2026, urging a bottom-up ...
PRINCETON, N.J., June 25, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries ...
Get the latest Sun Pharma Advanced Research Company Ltd. share price today on NSE & BSE. Explore Sun Pharma Advanced Research Company Ltd. stock analysis, financial performance, market capitalization, ...
Sun Pharma concludes National B-school Competition SUN PRISM 2025: Our Bureau, Mumbai Thursday, December 11, 2025, 16:30 Hrs [IST] Sun Pharmaceutical Industries Limited, India’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results